{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:58:39Z","timestamp":1793293119483,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11033-021-06787-y","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T16:26:17Z","timestamp":1634660777000},"page":"8181-8194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Zebrafish an experimental model of Huntington\u2019s disease: molecular aspects, therapeutic targets and current challenges"],"prefix":"10.1007","volume":"48","author":[{"given":"Vishal","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5168-4930","authenticated-orcid":false,"given":"Arti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"6787_CR1","unstructured":"Exuzides A, Reddy SR, Chang E, Paydar C, Yohrling G (2020) Epidemiology of Huntington\u2019s disease in the US Medicaid population. Prevalence 5:10.10"},{"key":"6787_CR2","first-page":"1086","volume":"20","author":"V Kumar","year":"2021","unstructured":"Kumar V, Singh A (2021) Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: an opinion. EXCLI J 20:1086","journal-title":"EXCLI J"},{"key":"6787_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbr.2014.01.048","volume":"264","author":"J Chakraborty","year":"2014","unstructured":"Chakraborty J, Nthenge-Ngumbau D, Rajamma U, Mohanakumar K (2014) Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. Behav Brain Res 264:91\u2013104","journal-title":"Behav Brain Res"},{"issue":"1","key":"6787_CR4","first-page":"21","volume":"31","author":"A Montoya","year":"2006","unstructured":"Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington\u2019s disease. J Psychiatry Neurosci 31(1):21","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"6787_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ana.410360406","volume":"36","author":"EK Richfield","year":"1994","unstructured":"Richfield EK, Herkenham M (1994) Selective vulnerability in Huntington\u2019s disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 36(4):577\u2013584","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association the Child Neurology Society"},{"key":"6787_CR6","doi-asserted-by":"crossref","unstructured":"Reiner A, Dragatsis I, Dietrich P (2011) Genetics and neuropathology of Huntington\u2019s disease. Int Rev Neurobiol 98:325\u2013372","DOI":"10.1016\/B978-0-12-381328-2.00014-6"},{"issue":"2","key":"6787_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nurt.2008.01.003","volume":"5","author":"SM Hersch","year":"2008","unstructured":"Hersch SM, Rosas HD (2008) Neuroprotection for Huntington\u2019s disease: ready, set, slow. Neurotherapeutics 5(2):226\u2013236","journal-title":"Neurotherapeutics"},{"key":"6787_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.neubiorev.2014.06.013","volume":"45","author":"S Das","year":"2014","unstructured":"Das S, Rajanikant G (2014) Huntington disease: can a zebrafish trail leave more than a ripple? Neurosci Biobehav Rev 45:258\u2013261","journal-title":"Neuroscience Biobehavioral Reviews"},{"issue":"6","key":"6787_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuro.2011.05.010","volume":"32","author":"EP Rico","year":"2011","unstructured":"Rico EP, Rosemberg DB, da Silveira Langoni A, Souto AA, Dias RD, Bogo MR, Bonan CD, Souza DO (2011) Chronic ethanol treatment alters purine nucleotide hydrolysis and nucleotidase gene expression pattern in zebrafish brain. Neurotoxicology 32(6):871\u2013878","journal-title":"Neurotoxicology"},{"key":"6787_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2020.108772","volume-title":"Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults","author":"MT Wiprich","year":"2020","unstructured":"Wiprich MT, Zanandrea R, Altenhofen S, Bonan CD (2020) Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults. Toxicol Comp Biochem Pharmacol 234:108772"},{"issue":"1-2","key":"6787_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0378-1119(98)00342-4","volume":"217","author":"CA Karlovich","year":"1998","unstructured":"Karlovich CA, John RM, Ramirez L, Stainier DY, Myers RM (1998) Characterization of the Huntington\u2019s disease (HD) gene homolog in the zebrafish Danio rerio. Gene 217(1\u20132):117\u2013125","journal-title":"Gene"},{"issue":"5","key":"6787_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P (2008) Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat Chem Biol 4(5):295\u2013305","journal-title":"Nature chemical biology"},{"issue":"3","key":"6787_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11910-011-0182-2","volume":"11","author":"Y Xi","year":"2011","unstructured":"Xi Y, Noble S, Ekker M (2011) Modeling neurodegeneration in zebrafish. Curr Neurol Neurosci Rep 11(3):274\u2013282","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"16","key":"6787_CR14","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/hmg\/ddm138","volume":"16","author":"AL Lumsden","year":"2007","unstructured":"Lumsden AL, Henshall TL, Dayan S, Lardelli MT, Richards RI (2007) Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum Mol Genet 16(16):1905\u20131920","journal-title":"Human molecular genetics"},{"issue":"3","key":"6787_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90(3):537\u2013548","journal-title":"Cell"},{"issue":"5","key":"6787_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/BF02943258","volume":"163","author":"P Morrison","year":"1994","unstructured":"Morrison P, Nevin N (1994) Serum iron, total iron binding capacity and ferritin in early Huntington disease patients. Ir J Med Sci 163(5):236\u2013237","journal-title":"Ir J Med Sci"},{"issue":"24","key":"6787_CR17","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1093\/hmg\/ddp455","volume":"18","author":"TL Henshall","year":"2009","unstructured":"Henshall TL, Tucker B, Lumsden AL, Nornes S, Lardelli MT, Richards RI (2009) Selective neuronal requirement for huntingtin in the developing zebrafish. Hum Mol Genet 18(24):4830\u20134842","journal-title":"Human molecular genetics"},{"key":"6787_CR18","doi-asserted-by":"crossref","unstructured":"Caviston JP, Ross JL, Antony SM, Tokito M, Holzbaur EL (2007) Huntingtin facilitates dynein\/dynactin-mediated vesicle transport. Proc Natl Acad Sci USA 104(24):10045\u201310050","DOI":"10.1073\/pnas.0610628104"},{"issue":"12","key":"6787_CR19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/emmm.201000102","volume":"2","author":"V Costa","year":"2010","unstructured":"Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D, Malorni W, Davies KJ, Carafoli E, Scorrano L (2010) Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli. EMBO Mol Med 2(12):490\u2013503","journal-title":"EMBO molecular medicine"},{"issue":"3","key":"6787_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","volume":"67","author":"JD Godin","year":"2010","unstructured":"Godin JD, Colombo K, Molina-Calavita M, Keryer G, Zala D, Charrin BC, Dietrich P, Volvert M-L, Guillemot F, Dragatsis I (2010) Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 67(3):392\u2013406","journal-title":"Neuron"},{"issue":"4","key":"6787_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.stemcr.2014.02.011","volume":"2","author":"S Elias","year":"2014","unstructured":"Elias S, Thion MS, Yu H, Sousa CM, Lasgi C, Morin X, Humbert S (2014) Huntingtin regulates mammary stem cell division and differentiation. Stem Cell Rep 2(4):491\u2013506","journal-title":"Stem cell reports"},{"issue":"1","key":"6787_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ydbio.2019.10.037","volume":"458","author":"H Sidik","year":"2020","unstructured":"Sidik H, Ang CJ, Pouladi MA (2020) Huntingtin confers fitness but is not embryonically essential in zebrafish development. Dev Biol 458(1):98\u2013105","journal-title":"Dev Biol"},{"issue":"1","key":"6787_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-213X-5-17","volume":"5","author":"JM Woda","year":"2005","unstructured":"Woda JM, Calzonetti T, Hilditch-Maguire P, Duyao MP, Conlon RA, MacDonald ME (2005) Inactivation of the Huntington\u2019s disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo. BMC Dev Biol 5(1):17","journal-title":"BMC Dev Biol"},{"issue":"19","key":"6787_CR24","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1093\/hmg\/9.19.2789","volume":"9","author":"P Hilditch-Maguire","year":"2000","unstructured":"Hilditch-Maguire P, Trettel F, Passani LA, Auerbach A, Persichetti F, MacDonald ME (2000) Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet 9(19):2789\u20132797","journal-title":"Human molecular genetics"},{"issue":"2","key":"6787_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10158-013-0158-9","volume":"13","author":"MM Idris","year":"2013","unstructured":"Idris MM, Thorndyke MC, Brown ER (2013) Evidence for dynamic and multiple roles for huntingtin in Ciona intestinalis. Invertebr Neurosci 13(2):151\u2013165","journal-title":"Invertebr Neurosci"},{"issue":"11","key":"6787_CR26","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur J Neurosci 27(11):2803\u20132820","journal-title":"Eur J Neurosci"},{"issue":"52","key":"6787_CR27","doi-asserted-by":"publisher","first-page":"41299","DOI":"10.1074\/jbc.M008408200","volume":"275","author":"AS Hackam","year":"2000","unstructured":"Hackam AS, Yassa AS, Singaraja R, Metzler M, Gutekunst C-A, Gan L, Warby S, Wellington CL, Vaillancourt J, Chen N (2000) Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J Biol Chem 275(52):41299\u201341308","journal-title":"J Biol Chem"},{"key":"6787_CR28","doi-asserted-by":"crossref","unstructured":"Marcora E, Gowan K, Lee JE (2003) Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2. Proc Natl Acad Sci 100(16):9578\u20139583","DOI":"10.1073\/pnas.1133382100"},{"issue":"25","key":"6787_CR29","doi-asserted-by":"publisher","first-page":"19035","DOI":"10.1074\/jbc.C000180200","volume":"275","author":"YF Liu","year":"2000","unstructured":"Liu YF, Dorow D, Marshall J (2000) Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin. J Biol Chem 275(25):19035\u201319040","journal-title":"J Biol Chem"},{"issue":"5","key":"6787_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1523\/JNEUROSCI.6039-08.2009","volume":"29","author":"H Diekmann","year":"2009","unstructured":"Diekmann H, Anichtchik O, Fleming A, Futter M, Goldsmith P, Roach A, Rubinsztein DC (2009) Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. J Neurosci 29(5):1343\u20131349","journal-title":"J Neurosci"},{"issue":"20","key":"6787_CR31","doi-asserted-by":"publisher","first-page":"16624","DOI":"10.1074\/jbc.M007753200","volume":"276","author":"R Jakobi","year":"2001","unstructured":"Jakobi R, Moertl E, Koeppel MA (2001) p21-activated protein kinase \u03b3-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J Biol Chem 276(20):16624\u201316634","journal-title":"J Biol Chem"},{"issue":"6","key":"6787_CR32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1242\/jcs.050013","volume":"122","author":"S Luo","year":"2009","unstructured":"Luo S, Rubinsztein DC (2009) Huntingtin promotes cell survival by preventing Pak2 cleavage. J Cell Sci 122(6):875\u2013885","journal-title":"Journal of cell science"},{"key":"6787_CR33","doi-asserted-by":"crossref","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu Y-Z, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA 97(12):6763\u20136768","DOI":"10.1073\/pnas.100110097"},{"issue":"1","key":"6787_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T (2003) Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35(1):76\u201383","journal-title":"Nat Genet"},{"issue":"1","key":"6787_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng0903-13","volume":"35","author":"LM Thompson","year":"2003","unstructured":"Thompson LM (2003) An expanded role for wild-type huntingtin in neuronal transcription. Nat Genet 35(1):13\u201314","journal-title":"Nat Genet"},{"issue":"23","key":"6787_CR36","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1093\/hmg\/11.23.2815","volume":"11","author":"RR Singaraja","year":"2002","unstructured":"Singaraja RR, Hadano S, Metzler M, Givan S, Wellington CL, Warby S, Yanai A, Gutekunst C-A, Leavitt BR, Yi H (2002) HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum Mol Genet 11(23):2815\u20132828","journal-title":"Human molecular genetics"},{"key":"6787_CR37","first-page":"65","volume":"5","author":"J Schulte","year":"2011","unstructured":"Schulte J, Littleton JT (2011) The biological function of the Huntingtin protein and its relevance to Huntington\u2019s Disease pathology. Curr Trends Neurol 5:65","journal-title":"Current trends in neurology"},{"key":"6787_CR38","doi-asserted-by":"crossref","unstructured":"Paine H (2015) Does loss of the normal protein function contribute to the pathogenesis of Huntington\u2019s disease? Biosci Horizons Int J Student Res 8:hzv005","DOI":"10.1093\/biohorizons\/hzv005"},{"key":"6787_CR39","doi-asserted-by":"crossref","unstructured":"Balchin D, Hayer-Hartl M, Hartl FU (2016) In vivo aspects of protein folding and quality control. Science 353(6294):aac4354","DOI":"10.1126\/science.aac4354"},{"key":"6787_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev-biochem-060614-033955","volume":"84","author":"J Labbadia","year":"2015","unstructured":"Labbadia J, Morimoto RI (2015) The biology of proteostasis in aging and disease. Annu Rev Biochem 84:435\u2013464","journal-title":"Annual review of biochemistry"},{"issue":"R2","key":"6787_CR41","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","volume":"16","author":"J Shao","year":"2007","unstructured":"Shao J, Diamond MI (2007) Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum Mol Genet 16(R2):R115\u2013R123","journal-title":"Human molecular genetics"},{"issue":"1","key":"6787_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-01510-z","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder A, Landles C, Ghosh R, Howland D, Myers RH, Faull RL, Tabrizi SJ, Bates GP (2017) The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci Rep 7(1):1\u201310","journal-title":"Scientific reports"},{"issue":"19","key":"6787_CR43","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1093\/hmg\/ddx260","volume":"26","author":"J Branco-Santos","year":"2017","unstructured":"Branco-Santos J, Herrera F, Po\u00e7as GM, Pires-Afonso Y, Giorgini F, Domingos PM, Outeiro TF (2017) Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity. Hum Mol Genet 26(19):3763\u20133775","journal-title":"Human molecular genetics"},{"key":"6787_CR44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ijbiomac.2017.07.116","volume":"105","author":"TN Shamsi","year":"2017","unstructured":"Shamsi TN, Athar T, Parveen R, Fatima S (2017) A review on protein misfolding, aggregation and strategies to prevent related ailments. Int J Biol Macromol 105:993\u20131000","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"6787_CR45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jnc.14723","volume":"150","author":"AI Smith-Dijak","year":"2019","unstructured":"Smith-Dijak AI, Sepers MD, Raymond LA (2019) Alterations in synaptic function and plasticity in Huntington disease. J Neurochem 150(4):346\u2013365","journal-title":"Journal of neurochemistry"},{"key":"6787_CR46","doi-asserted-by":"crossref","unstructured":"Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL, MacAskill AF, Rostaing P, Lumb MJ, Humbert S, Triller A, Saudou F, Yan Z (2010) Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron 65(1):53\u201365","DOI":"10.1016\/j.neuron.2009.12.007"},{"issue":"1","key":"6787_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M, Dompierre JP, Rangone H, Cordeli\u00e8res FP, De Mey J, MacDonald ME, Le\u00dfmann V, Humbert S (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118(1):127\u2013138","journal-title":"Cell"},{"issue":"7","key":"6787_CR48","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nn.2346","volume":"12","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, You Y-M, Pollema SL, Kaminska A, Liu K, Yoshioka K, Bj\u00f6rkblom B, Coffey ET, Bagnato C, Han D (2009) Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci 12(7):864","journal-title":"Nature neuroscience"},{"issue":"12","key":"6787_CR49","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2056","volume":"15","author":"S-i Okamoto","year":"2009","unstructured":"Okamoto S-i, Pouladi MA, Talantova M, Yao D, Xia P, Ehrnhoefer DE, Zaidi R, Clemente A, Kaul M, Graham RK (2009) Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med 15(12):1407\u20131413","journal-title":"Nature medicine"},{"issue":"10","key":"6787_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrn.2016.92","volume":"17","author":"I P\u00e9rez-Ota\u00f1o","year":"2016","unstructured":"P\u00e9rez-Ota\u00f1o I, Larsen RS, Wesseling JF (2016) Emerging roles of GluN3-containing NMDA receptors in the CNS. Nat Rev Neurosci 17(10):623","journal-title":"Nat Rev Neurosci"},{"key":"6787_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nbd.2016.04.001","volume":"93","author":"K Mahfooz","year":"2016","unstructured":"Mahfooz K, Marco S, Mart\u00ednez-Turrillas R, Raja MK, P\u00e9rez-Ota\u00f1o I, Wesseling JF (2016) GluN3A promotes NMDA spiking by enhancing synaptic transmission in Huntington\u2019s disease models. Neurobiol Dis 93:47\u201356","journal-title":"Neurobiol Dis"},{"issue":"9","key":"6787_CR52","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/emboj\/17.9.2534","volume":"17","author":"RE van Kesteren","year":"1998","unstructured":"van Kesteren RE, Fainzilber M, Hauser G, van Minnen J, Vreugdenhil E, Smit AB, Ib\u00e1\u00f1ez CF, Geraerts WP, Bulloch AG (1998) Early evolutionary origin of the neurotrophin receptor family. EMBO J 17(9):2534\u20132542","journal-title":"EMBO J"},{"issue":"5","key":"6787_CR53","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S0959-4388(99)00011-2","volume":"9","author":"F Hallb\u00f6\u00f6k","year":"1999","unstructured":"Hallb\u00f6\u00f6k F (1999) Evolution of the vertebrate neurotrophin and Trk receptor gene families. Curr Opin Neurobiol 9(5):616\u2013621","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"6787_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms3490","volume":"4","author":"A Anastasia","year":"2013","unstructured":"Anastasia A, Deinhardt K, Chao MV, Will NE, Irmady K, Lee FS, Hempstead BL, Bracken C (2013) Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nat Commun 4(1):1\u201313","journal-title":"Nature communications"},{"issue":"10","key":"6787_CR55","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.3390\/ijms19103155","volume":"19","author":"C Lucini","year":"2018","unstructured":"Lucini C, D\u2019Angelo L, Cacialli P, Palladino A, De Girolamo P (2018) BDNF, brain, and regeneration: insights from zebrafish. Int J Mol Sci 19(10):3155","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6787_CR56","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/gt.2012.84","volume":"20","author":"P Conforti","year":"2013","unstructured":"Conforti P, Monteys AM, Zuccato C, Buckley N, Davidson B, Cattaneo E (2013) In vivo delivery of DN: REST improves transcriptional changes of REST-regulated genes in HD mice. Gene Therapy 20(6):678","journal-title":"Gene therapy"},{"issue":"6555","key":"6787_CR57","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/378398a0","volume":"378","author":"X-J Li","year":"1995","unstructured":"Li X-J, Li S-H, Sharp AH, Nucifora FC, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378(6555):398\u2013402","journal-title":"Nature"},{"issue":"1","key":"6787_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-34883-w","volume":"8","author":"C Yu","year":"2018","unstructured":"Yu C, Li CH, Chen S, Yoo H, Qin X, Park H (2018) Decreased BDNF release in cortical neurons of a knock-in mouse model of Huntington\u2019s disease. Sci Rep 8(1):1\u201311","journal-title":"Scientific reports"},{"issue":"3","key":"6787_CR59","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","volume":"23","author":"S Gin\u00e9s","year":"2006","unstructured":"Gin\u00e9s S, Bosch M, Marco S, Gavalda N, D\u00edaz-Hern\u00e1ndez M, Lucas JJ, Canals JM, Alberch J (2006) Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain. Eur J Neurosci 23(3):649\u2013658","journal-title":"Eur J Neurosci"},{"key":"6787_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","volume":"33","author":"JL Plotkin","year":"2015","unstructured":"Plotkin JL, Surmeier DJ (2015) Corticostriatal synaptic adaptations in Huntington\u2019s disease. Curr Opin Neurobiol 33:53\u201362","journal-title":"Curr Opin Neurobiol"},{"issue":"4","key":"6787_CR61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000375447","volume":"15","author":"A Silva","year":"2015","unstructured":"Silva A, Naia L, Dominguez A, Ribeiro M, Rodrigues J, Vieira OV, Lessmann V, Rego AC (2015) Overexpression of BDNF and full-length trkb receptor ameliorate striatal neural survival in huntington\u2019s disease. Neurodegen Dis 15(4):207\u2013218","journal-title":"Neurodegenerative Diseases"},{"issue":"10","key":"6787_CR62","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/ijms20102409","volume":"20","author":"G Fichi","year":"2019","unstructured":"Fichi G, Naef V, Barca A, Longo G, Fronte B, Verri T, Santorelli FM, Marchese M, Petruzzella V (2019) Fishing in the cell powerhouse: zebrafish as a tool for exploration of mitochondrial defects affecting the nervous system. Int J Mol Sci 20(10):2409","journal-title":"Int J Mol Sci"},{"issue":"2","key":"6787_CR63","doi-asserted-by":"publisher","first-page":"C371","DOI":"10.1152\/ajpcell.00281.2005","volume":"290","author":"L-Y Lin","year":"2006","unstructured":"Lin L-Y, Horng J-L, Kunkel JG, Hwang P-P (2006) Proton pump-rich cell secretes acid in skin of zebrafish larvae. Am J Physiol Physiol 290(2):C371\u2013C378","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"6787_CR64","doi-asserted-by":"crossref","unstructured":"Jung Kim M, Ho Kang K, Kim C-H, Choi S-Y (2008) Real-time imaging of mitochondria in transgenic zebrafish expressing mitochondrially targeted GFP. Biotechniques 45(3):331\u2013334","DOI":"10.2144\/000112909"},{"key":"6787_CR65","doi-asserted-by":"crossref","unstructured":"Lyons DA, Naylor SG, Mercurio S, Dominguez C, Talbot WS (2008) KBP is essential for axonal structure, outgrowth and maintenance in zebrafish, providing insight into the cellular basis of Goldberg\u2013Shprintzen syndrome. Development 135(3):599\u2013608","DOI":"10.1242\/dev.012377"},{"issue":"12","key":"6787_CR66","doi-asserted-by":"publisher","first-page":"e8329","DOI":"10.1371\/journal.pone.0008329","volume":"4","author":"Y Song","year":"2009","unstructured":"Song Y, Selak MA, Watson CT, Coutts C, Scherer PC, Panzer JA, Gibbs S, Scott MO, Willer G, Gregg RG (2009) Mechanisms underlying metabolic and neural defects in zebrafish and human multiple acyl-CoA dehydrogenase deficiency (MADD). PLoS ONE 4(12):e8329","journal-title":"PLoS One"},{"issue":"9","key":"6787_CR67","doi-asserted-by":"publisher","first-page":"e25652","DOI":"10.1371\/journal.pone.0025652","volume":"6","author":"KD Stackley","year":"2011","unstructured":"Stackley KD, Beeson CC, Rahn JJ, Chan SS (2011) Bioenergetic profiling of zebrafish embryonic development. PLoS ONE 6(9):e25652","journal-title":"PLoS One"},{"issue":"4","key":"6787_CR68","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/aws036","volume":"135","author":"JJ Dowling","year":"2012","unstructured":"Dowling JJ, Arbogast S, Hur J, Nelson DD, McEvoy A, Waugh T, Marty I, Lunardi J, Brooks SV, Kuwada JY (2012) Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain 135(4):1115\u20131127","journal-title":"Brain"},{"issue":"6","key":"6787_CR69","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.bbagen.2016.03.007","volume":"1860","author":"G Bergamin","year":"2016","unstructured":"Bergamin G, Cieri D, Vazza G, Argenton F, Mostacciuolo ML (2016) Zebrafish Tg (hb9: MTS-Kaede): a new in vivo tool for studying the axonal movement of mitochondria. Biochim Biophys Acta 1860(6):1247\u20131255","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"key":"6787_CR70","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fcell.2018.00144","volume":"6","author":"A Mandal","year":"2018","unstructured":"Mandal A, Pinter K, Drerup CM (2018) Analyzing neuronal mitochondria in vivo using fluorescent reporters in zebrafish. Front Cell Dev Biol 6:144","journal-title":"Frontiers in cell developmental biology"},{"key":"6787_CR71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.talanta.2017.08.085","volume":"178","author":"P Yue","year":"2018","unstructured":"Yue P, Yang X, Ning P, Xi X, Yu H, Feng Y, Shao R, Meng X (2018) A mitochondria-targeted ratiometric two-photon fluorescent probe for detecting intracellular cysteine and homocysteine. Talanta 178:24\u201330","journal-title":"Talanta"},{"issue":"8","key":"6787_CR72","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst C-A, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5(8):731\u2013736","journal-title":"Nature neuroscience"},{"issue":"14","key":"6787_CR73","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13(14):1407\u20131420","journal-title":"Human molecular genetics"},{"issue":"2","key":"6787_CR74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI45691","volume":"121","author":"F Mochel","year":"2011","unstructured":"Mochel F, Haller RG (2011) Energy deficit in Huntington disease: why it matters. J Clin Investig 121(2):493\u2013499","journal-title":"J Clin Investig"},{"key":"6787_CR75","doi-asserted-by":"crossref","unstructured":"Redza-Dutordoir M, Averill-Bates DA (2016) Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 1863(12):2977\u20132992","DOI":"10.1016\/j.bbamcr.2016.09.012"},{"issue":"1","key":"6787_CR76","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127(1):59\u201369","journal-title":"Cell"},{"issue":"4","key":"6787_CR77","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3892\/etm.2016.3566","volume":"12","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Chen WW, Zhang X (2016) Huntington\u2019s disease: molecular basis of pathology and status of current therapeutic approaches. Exp Therap Med 12(4):1951\u20131956","journal-title":"Experimental therapeutic medicine"},{"key":"6787_CR78","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","volume":"198","author":"LA Raymond","year":"2011","unstructured":"Raymond LA, Andr\u00e9 VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS (2011) Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function. Neuroscience 198:252\u2013273","journal-title":"Neuroscience"},{"issue":"12","key":"6787_CR79","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1074\/jbc.M607865200","volume":"282","author":"NW Schiffer","year":"2007","unstructured":"Schiffer NW, Broadley SA, Hirschberger T, Tavan P, Kretzschmar HA, Giese A, Haass C, Hartl FU, Schmid B (2007) Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J Biol Chem 282(12):9195\u20139203","journal-title":"J Biol Chem"},{"issue":"1","key":"6787_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-015-0063-2","volume":"10","author":"MB Veldman","year":"2015","unstructured":"Veldman MB, Rios-Galdamez Y, Lu X-H, Gu X, Qin W, Li S, Yang XW, Lin S (2015) The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington\u2019s disease model. Mol Neurodegener 10(1):1\u201316","journal-title":"Molecular neurodegeneration"},{"issue":"1","key":"6787_CR81","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/exnr.1993.1008","volume":"119","author":"F Filloux","year":"1993","unstructured":"Filloux F, Townsend JJ (1993) Pre-and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 119(1):79\u201388","journal-title":"Exp Neurol"},{"key":"6787_CR82","doi-asserted-by":"crossref","unstructured":"Cepeda C, Murphy KP, Parent M, Levine MS (2014) The role of dopamine in Huntington\u2019s disease. Prog Brain Res 211:235\u2013254","DOI":"10.1016\/B978-0-444-63425-2.00010-6"},{"issue":"3","key":"6787_CR83","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/WNF.0b013e3180ca77ea","volume":"31","author":"S Frank","year":"2008","unstructured":"Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F (2008) A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clin Neuropharmacol 31(3):127\u2013133","journal-title":"Clin Neuropharmacol"},{"key":"6787_CR84","doi-asserted-by":"crossref","unstructured":"Abd-Elrahman KS, Hamilton A, Hutchinson SR, Liu F, Russell RC, Ferguson SS (2017) mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington\u2019s disease. Sci Signal 10(510):eaan6387","DOI":"10.1126\/scisignal.aan6387"},{"issue":"1","key":"6787_CR85","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mehy.2010.09.003","volume":"76","author":"M Anitha","year":"2011","unstructured":"Anitha M, Nandhu M, Anju T, Jes P, Paulose C (2011) Targeting glutamate mediated excitotoxicity in Huntington\u2019s disease: neural progenitors and partial glutamate antagonist\u2013memantine. Med Hypotheses 76(1):138\u2013140","journal-title":"Medical hypotheses"},{"issue":"5180","key":"6787_CR86","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1126\/science.8091209","volume":"265","author":"AM Graybiel","year":"1994","unstructured":"Graybiel AM, Aosaki T, Flaherty AW, Kimura M (1994) The basal ganglia and adaptive motor control. Science 265(5180):1826\u20131831","journal-title":"Science"},{"issue":"7","key":"6787_CR87","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2967\/jnumed.109.074120","volume":"51","author":"H Boecker","year":"2010","unstructured":"Boecker H, Weindl A, Brooks DJ, Ceballos-Baumann AO, Liedtke C, Miederer M, Sprenger T, Wagner KJ, Miederer I (2010) GABAergic dysfunction in essential tremor: an 11\u00a0C-flumazenil PET study. J Nucl Med 51(7):1030\u20131035","journal-title":"J Nucl Med"},{"issue":"3","key":"6787_CR88","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-160205","volume":"5","author":"A Kumar","year":"2016","unstructured":"Kumar A, Ratan RR (2016) Oxidative stress and Huntington\u2019s disease: The good, the bad, and the ugly. J Huntington Dis 5(3):217\u2013237","journal-title":"Journal of Huntington\u2019s disease"},{"issue":"3","key":"6787_CR89","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s12640-018-9989-9","volume":"35","author":"MM Essa","year":"2019","unstructured":"Essa MM, Moghadas M, Ba-Omar T, Qoronfleh MW, Guillemin GJ, Manivasagam T, Justin-Thenmozhi A, Ray B, Bhat A, Chidambaram SB (2019) Protective effects of antioxidants in Huntington\u2019s disease: an extensive review. Neurotox Res 35(3):739\u2013774","journal-title":"Neurotox Res"},{"issue":"3","key":"6787_CR90","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342(3):619\u2013630","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"6787_CR91","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","volume":"16","author":"CT Aiken","year":"2004","unstructured":"Aiken CT, Tobin AJ, Schweitzer ES (2004) A cell-based screen for drugs to treat Huntington\u2019s disease. Neurobiol Dis 16(3):546\u2013555","journal-title":"Neurobiol Dis"},{"issue":"1","key":"6787_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-72613-3","volume":"10","author":"S Aravindan","year":"2020","unstructured":"Aravindan S, Chen S, Choudhry H, Molfetta C, Chen KY, Liu AY (2020) osmolytes dynamically regulate mutant Huntingtin aggregation and cReB function in Huntington\u2019s disease cell models. Sci Rep 10(1):1\u201312","journal-title":"Scientific reports"},{"issue":"3","key":"6787_CR93","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11011-019-00405-4","volume":"34","author":"K Pierzynowska","year":"2019","unstructured":"Pierzynowska K, Gaffke L, Cyske Z, W\u0119grzyn G (2019) Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington\u2019s disease patients. Metab Brain Dis 34(3):715\u2013720","journal-title":"Metabolic brain disease"},{"issue":"7","key":"6787_CR94","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/77528","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6(7):797\u2013801","journal-title":"Nature medicine"},{"key":"6787_CR95","doi-asserted-by":"crossref","unstructured":"Kumar V, Kundu S, Singh A, Singh S (2021) Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: Current targets and future perspective. Current Neuropharmacology","DOI":"10.2174\/1570159X19666210609160017"},{"key":"6787_CR96","doi-asserted-by":"crossref","unstructured":"Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, Sathasivam K, Ghazi-Noori S, Mahal A, Lowden PA (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease. Proc Natl Acad Sci USA 100(4):2041\u20132046","DOI":"10.1073\/pnas.0437870100"},{"issue":"10","key":"6787_CR97","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrd.2018.133","volume":"17","author":"NS Caron","year":"2018","unstructured":"Caron NS, Dorsey ER, Hayden MR (2018) Therapeutic approaches to Huntington disease: from the bench to the clinic. Nat Rev Drug Discov 17(10):729\u2013750","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"6787_CR98","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL (2012) Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11(1):42\u201353","journal-title":"Lancet Neurol"},{"key":"6787_CR99","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2018.00329","volume":"11","author":"J Zheng","year":"2018","unstructured":"Zheng J, Winderickx J, Franssens V, Liu B (2018) A mitochondria-associated oxidative stress perspective on Huntington\u2019s disease. Front Mol Neurosci 11:329","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"6787_CR100","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for irnnairment of energy metabofism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy. Neurology 43(12):2689\u20132689","journal-title":"Neurology"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06787-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06787-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06787-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T22:08:32Z","timestamp":1675807712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06787-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":100,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6787"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06787-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"10 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors wish to confirm that there was no conflict of interest associated with this publication and there has been no significant financial support for this work that could influence its outcome.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable for the article submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All author give full content to publish the content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}